Long-Term Effectiveness of Human Papillomavirus Vaccination: Implications for Future Reduction in Cancer

Ann Intern Med. 2022 Jul;175(7):1037-1038. doi: 10.7326/M22-1309. Epub 2022 May 17.

Authors

Rebecca B Perkins¹, Debbie Saslow², Kristin Oliver³

Affiliations

¹ Department of Obstetrics and Gynecology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
² Prevention and Early Detection Department, American Cancer Society, Atlanta, Georgia.
³ Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 35576588
DOI: 10.7326/M22-1309

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cost-Benefit Analysis
Female
Human papillomavirus 18
Humans
Neoplasms*
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines*
Uterine Cervical Neoplasms* / prevention & control
Vaccination

Substances

Papillomavirus Vaccines